European Commission

News

Moderna's mResvia gets shot in the arm from EU contract

A new EU procurement contract could give Moderna's RSV shot mResvia, which has struggled to gain traction in the market, a welcome boost.

News

EU seeks advice on Sanofi's response to mismarketing claim

The EU is asking for feedback on measures proposed by Sanofi to address concerns about an allegedly misleading marketing campaign for a flu vaccine.

News

Sanofi faces EU investigation over flu shot marketing

The European Commission is investigating a marketing campaign run by Sanofi for a flu vaccine, to see if it disparaged its only rival in the market.

News

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

News

UCB brings first therapy for rare disease TK2d to EU

The EU has approved UCB's Kygevvi for rare disease TK2d, and Sanofi's acute GvHD therapy Rezurock, in a pair of decisions announced this morning.

News

Agreement reached on EU's new pharma legislation

Agreement has been reached on the reform of EU pharma legislation, but industry thinks it does not go far enough to restore the bloc's global status.

Moderna's mResvia gets shot in the arm from EU contract

EU seeks advice on Sanofi's response to mismarketing claim

Sanofi faces EU investigation over flu shot marketing

EU invests €30m to fight antimicrobial resistance

UCB brings first therapy for rare disease TK2d to EU

Agreement reached on EU's new pharma legislation

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

European Commission

Editor's Picks